Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC704421355;21356;21357 chr2:178724129;178724128;178724127chr2:179588856;179588855;179588854
N2AB672720404;20405;20406 chr2:178724129;178724128;178724127chr2:179588856;179588855;179588854
N2A580017623;17624;17625 chr2:178724129;178724128;178724127chr2:179588856;179588855;179588854
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCC
  • RefSeq wild type template codon: GGG
  • Domain: Ig-55
  • Domain position: 1
  • Structural Position: 1
  • Q(SASA): 0.1895
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/S rs773899102 -1.631 0.322 D 0.675 0.754 0.477685322099 gnomAD-2.1.1 8.13E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.8E-05 0
P/S rs773899102 -1.631 0.322 D 0.675 0.754 0.477685322099 gnomAD-4.0.0 6.85243E-06 None None None None N None 0 0 None 0 0 None 0 0 9.00607E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.703 likely_pathogenic 0.6568 pathogenic -1.466 Destabilizing 0.885 D 0.717 prob.delet. D 0.641854447 None None N
P/C 0.9778 likely_pathogenic 0.9793 pathogenic -1.361 Destabilizing 0.999 D 0.827 deleterious None None None None N
P/D 0.9981 likely_pathogenic 0.9987 pathogenic -1.402 Destabilizing 0.986 D 0.794 deleterious None None None None N
P/E 0.9935 likely_pathogenic 0.9952 pathogenic -1.43 Destabilizing 0.986 D 0.804 deleterious None None None None N
P/F 0.9957 likely_pathogenic 0.996 pathogenic -1.448 Destabilizing 0.993 D 0.847 deleterious None None None None N
P/G 0.9822 likely_pathogenic 0.9828 pathogenic -1.724 Destabilizing 0.91 D 0.803 deleterious None None None None N
P/H 0.9904 likely_pathogenic 0.9922 pathogenic -1.202 Destabilizing 0.999 D 0.827 deleterious D 0.658711386 None None N
P/I 0.9233 likely_pathogenic 0.945 pathogenic -0.866 Destabilizing 0.386 N 0.759 deleterious None None None None N
P/K 0.9948 likely_pathogenic 0.9966 pathogenic -1.044 Destabilizing 0.986 D 0.799 deleterious None None None None N
P/L 0.8532 likely_pathogenic 0.8622 pathogenic -0.866 Destabilizing 0.885 D 0.806 deleterious D 0.642258056 None None N
P/M 0.9841 likely_pathogenic 0.9856 pathogenic -0.766 Destabilizing 0.998 D 0.832 deleterious None None None None N
P/N 0.9962 likely_pathogenic 0.9972 pathogenic -0.908 Destabilizing 0.986 D 0.821 deleterious None None None None N
P/Q 0.9847 likely_pathogenic 0.9877 pathogenic -1.17 Destabilizing 0.993 D 0.801 deleterious None None None None N
P/R 0.9783 likely_pathogenic 0.9835 pathogenic -0.53 Destabilizing 0.982 D 0.833 deleterious D 0.658711386 None None N
P/S 0.9519 likely_pathogenic 0.952 pathogenic -1.438 Destabilizing 0.322 N 0.675 prob.neutral D 0.642056251 None None N
P/T 0.9278 likely_pathogenic 0.9351 pathogenic -1.36 Destabilizing 0.885 D 0.783 deleterious D 0.658509581 None None N
P/V 0.8269 likely_pathogenic 0.8556 pathogenic -1.033 Destabilizing 0.91 D 0.781 deleterious None None None None N
P/W 0.999 likely_pathogenic 0.9992 pathogenic -1.53 Destabilizing 0.999 D 0.764 deleterious None None None None N
P/Y 0.9974 likely_pathogenic 0.9976 pathogenic -1.21 Destabilizing 0.998 D 0.844 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.